Search Results - "Tae-Won Jang"

Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR Mutation.

Authors: Yeo, Chang Dong Park, Dong Won Yoon, Seong Hoon et al.

Source: Clinical Respiratory Journal. Jan2025, Vol. 19 Issue 1, p1-7. 7p.

Immune Aging Within the Tumor Microenvironment Predicts Survival in Lung Adenocarcinoma.

Authors: Kim, Taeyun Choi, Hyunji Jang, Tae Won et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1343. 11p.

Impact of Modifying Lazertinib Doses on Effectiveness and Safety in Patients With EGFR‐Positive Advanced Lung Cancer: A Multicenter, Prospective Observational Cohort Study.

Authors: Kim, Mi‐Hyun Lee, Min Ki Park, Ji Eun et al.

Source: Thoracic Cancer. May2025, Vol. 16 Issue 10, p1-4. 4p.

Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure.

Authors: Jayanti, Rannissa Puspita Cho, Yong-Soon Soedarsono, Soedarsono et al.

Source: PLoS ONE. 1/29/2025, Vol. 21 Issue 1, p1-20. 20p.

Association between the safety climate and occupational injury in the Korean working population: a cross-sectional study.

Authors: Jeehee Min Tae-Won Jang Hye-Eun Lee et al.

Source: Epidemiology & Health. 2024, Vol. 46, p1-9. 10p.

Temporal changes in tongue color during immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer: a prospective observational study using digital tongue diagnosis.

Authors: Cho, Eunbyul Choi, Woosu Lim, Jun Hyeok et al.

Source: Oncology Reviews. 2025, p1-12. 12p.

Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non--Small Cell Lung Cancer: Updated Analysis of the RESET Study.

Authors: Taeyun Kim Tae Won Jang Chang Min Choi et al.

Source: Cancer Research & Treatment. Oct2023, Vol. 55 Issue 4, p1152-1170. 19p.

Real‐world outcome of crizotinib for anaplastic lymphoma kinase‐positive lung cancer: Multicenter retrospective analysis in South Korea.

Authors: Jeon, Da Som Park, Cheol‐kyu Kim, Seung Joon et al.

Source: Thoracic Cancer. Feb2024, Vol. 15 Issue 6, p448-457. 10p.

A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation‐positive non‐small cell lung cancer (stage III) who have not progressed following definitive, platinum‐based, chemoradiation therapy (PLATINUM trial)

Authors: Choi, Juwhan Lee, Jeong Eun Choi, Chang‐Min et al.

Source: Thoracic Cancer. Dec2022, Vol. 13 Issue 23, p3431-3435. 5p.

Effect of Polycyclic Aromatic Hydrocarbons (PAHs) on Respiratory Diseases and the Risk Factors Related to Cancer.

Authors: Ravanbakhsh, Majid Yousefi, Homayon Lak, Elena et al.

Source: Polycyclic Aromatic Compounds. 2023, Vol. 43 Issue 9, p8371-8387. 17p.

Application of several machine learning algorithms for the prediction of afatinib treatment outcome in advanced‐stage EGFR‐mutated non‐small‐cell lung cancer.

Authors: Kim, Taeyun Lee, Sang Jin Jang, Tae‐Won

Source: Thoracic Cancer. Dec2022, Vol. 13 Issue 23, p3353-3361. 9p.

Clinical outcomes of hyperprogression based on volumetry in non‐small cell lung cancer after immune checkpoint inhibitor treatment.

Authors: Kim, Jehun Kim, Taeyun Jang, Tae Won et al.

Source: Thoracic Cancer. Aug2022, Vol. 13 Issue 15, p2170-2179. 10p.

Poor glycemic control in workers with diabetes mellitus in relation to long working hours: a cross-sectional study.

Authors: Jongin LEE Hyoung-Ryoul KIM Tae-Won JANG et al.

Source: Industrial Health. 2020, Vol. 58 Issue 5, p451-459.

Trend of prevalence and characteristics of preserved ratio impaired spirometry (PRISm): Nationwide population-based survey between 2010 and 2019.

Authors: Choi, Hyunji Oak, Chul-Ho Jung, Mann-Hong et al.

Source: PLoS ONE. 7/23/2024, Vol. 19 Issue 7, p1-11. 11p.

Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer.

Authors: Lee, Su Yeon Kim, Young Chul Lee, Kye Young et al.

Source: Thoracic Cancer. Feb2022, Vol. 13 Issue 3, p380-385. 6p.

Beneficial role of Boehmeria nivea in health and phytochemical constituents.

Authors: Choi, Jungwon Nguyen, Quynh Nhu Baek, Ji Yun et al.

Source: Journal of Food Biochemistry. Dec2022, Vol. 46 Issue 12, p1-13. 13p.

Subjects: Ramie, Phenolic acids, Caffeic acid, Normal-phase chromatography, Cancer cell growth, Inflammatory mediators, Ethyl acetate, Buckwheat

Geographic Terms: South Korea

Phase II open‐label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid‐Lung‐A.

Authors: Park, Cheol‐Kyu Lee, Sung‐Yong Lee, Jae Cheol et al.

Source: Thoracic Cancer. Feb2021, Vol. 12 Issue 4, p444-452. 9p.

Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea.

Authors: Sun Min Lim Sang-We Kim Byoung Chul Cho et al.

Source: Cancer Research & Treatment. Oct2020, Vol. 52 Issue 4, p1112-1119. 8p.

Human work in the shift to Industry 4.0: a road map to the management of technological changes in manufacturing.

Authors: Reiman, Arto Kaivo-oja, Jari Parviainen, Elina et al.

Source: International Journal of Production Research. Aug2024, Vol. 62 Issue 16, p5613-5630. 18p.

Subjects: Road maps, Technological innovations, Industry 4.0

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer.

Authors: Jang Ho Lee Eun Young Kim Cheol-Kyu Park et al.

Source: Cancer Research & Treatment. Jan2023, Vol. 55 Issue 1, p112-122. 11p.